Sveinsson Olafur A, Orvar Kjartan B, Birgisson Sigurbjorn, Agnarsdottir Margret, Jonasson Jon Gunnlaugur
Department of Medicine, Division of Gastroenterology, Landspitali University Hospital, Reykjavik, Iceland.
Scand J Gastroenterol. 2008 Aug;43(8):955-60. doi: 10.1080/00365520801958600.
The long-term natural history of collagenous colitis (CC) and lymphocytic colitis (LC) is not well known. The few reports available that address these issues have a limited follow-up. The aims of this study were to evaluate the natural history of microscopic colitis (MC), to describe the treatment medications prescribed and to assess the use of non-steroidal anti-inflammatory drugs (NSAIDs) in MC.
This study is based on an earlier epidemiological study conducted in Iceland where 125 patients with MC (71 with CC and 54 with LC) were diagnosed in the period 1995-99. All patients still alive and available were questioned about symptoms, treatment and NSAID use in the 3 months preceding the interview.
In a mean follow-up time of 6.4 years from diagnosis, 15% of the patients had diarrhoeal symptoms more than once a week, 30% less than once a week and 55% had no diarrhoea. Abdominal pain was reported in 18% of the patients. There was no statistically significant difference in symptoms of CC and LC patients. Forty-eight patients (50%) were receiving medication for MC, 16% used aminosalicylates and 14% corticosteroids. Patients using medication for MC had significantly more diarrhoeal symptoms compared with those who did not (p = 0.002). Patients using NSAIDs regularly or as required, statistically did not have more symptoms related to MC than non-NSAID users.
Only a minority of patients with MC had diarrhoea more than once a week in a long-term follow-up and the symptom pattern was similar between CC and LC patients. The use of NSAIDs was not associated with more diarrhoeal symptoms.
胶原性结肠炎(CC)和淋巴细胞性结肠炎(LC)的长期自然病史尚不为人所知。现有的少数涉及这些问题的报告随访时间有限。本研究的目的是评估显微镜下结肠炎(MC)的自然病史,描述所开具的治疗药物,并评估MC患者中使用非甾体抗炎药(NSAIDs)的情况。
本研究基于冰岛早期进行的一项流行病学研究,在1995 - 1999年期间诊断出125例MC患者(71例CC患者和54例LC患者)。所有在世且可联系到的患者均被询问了访谈前3个月的症状、治疗情况及NSAIDs使用情况。
从诊断开始的平均随访时间为6.4年,15%的患者每周腹泻症状超过一次,30%的患者每周少于一次,55%的患者无腹泻。18%的患者报告有腹痛。CC和LC患者的症状无统计学显著差异。48例患者(50%)正在接受MC治疗,16%使用氨基水杨酸制剂,14%使用皮质类固醇。与未接受MC治疗的患者相比,接受MC治疗的患者腹泻症状明显更多(p = 0.002)。定期或按需使用NSAIDs的患者,与未使用NSAIDs的患者相比,在统计学上与MC相关的症状并无更多。
在长期随访中,只有少数MC患者每周腹泻超过一次,CC和LC患者的症状模式相似。NSAIDs的使用与更多腹泻症状无关。